CN105175580A - Beta-cyclodextrin derivatives based on amino acid reduced product alkamine and preparation method and application of beta-cyclodextrin derivative - Google Patents

Beta-cyclodextrin derivatives based on amino acid reduced product alkamine and preparation method and application of beta-cyclodextrin derivative Download PDF

Info

Publication number
CN105175580A
CN105175580A CN201510661366.8A CN201510661366A CN105175580A CN 105175580 A CN105175580 A CN 105175580A CN 201510661366 A CN201510661366 A CN 201510661366A CN 105175580 A CN105175580 A CN 105175580A
Authority
CN
China
Prior art keywords
beta
cyclodextrin
modifies
application
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510661366.8A
Other languages
Chinese (zh)
Inventor
纪红兵
朱庆英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Yat Sen University
National Sun Yat Sen University
Original Assignee
National Sun Yat Sen University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Sun Yat Sen University filed Critical National Sun Yat Sen University
Priority to CN201510661366.8A priority Critical patent/CN105175580A/en
Publication of CN105175580A publication Critical patent/CN105175580A/en
Pending legal-status Critical Current

Links

Landscapes

  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

The invention discloses beta-cyclodextrin derivatives based on amino acid reduced product alkamine and a preparation method and application of the beta-cyclodextrin derivatives. The beta-cyclodextrin derivatives are the L-phenylglycinol modified beta-cyclodextrin, D-phenylalaninol modified beta-cyclodextrin, L-phenylalaninol modified beta-cyclodextrin, L-alaninol modified beta-cyclodextrin, L-valinol modified beta-cyclodextrin, L-isoleucinol modified beta-cyclodextrin and L-leucinol modified beta-cyclodextrin. Mono-(6-O-p-tolylsulfonyl)-beta-cyclodextrin and alkamine are dissolved in an anhydrous polar aprotic solvent, and the beta-cyclodextrin derivatives are prepared in the nitrogen atmosphere. According to the method, the reaction condition is moderate, and the yield is high. The obtained beta-cyclodextrin derivatives and metal ions can be matched to be used for water-phase organocatalysis asymmetric synthesis reactions to recognize different guest molecules.

Description

A kind of based on amino acid reduzate amino alcohol beta-cyclodextrin derivative and preparation method thereof and application
Technical field
The present invention relates to a kind of based on amino acid reduzate amino alcohol beta-cyclodextrin derivative preparation method and application thereof, belong to catalysis organic synthesis field.
Background technology
Beta-cyclodextrin (β-cyclodextrin, be called for short β-CD) be a kind of by 7 glucose units by α-1, the cyclic oligomer glycan molecule that 4-glycosidic link is formed by connecting, in cone cylindrical cavity structure, and cavity inside becomes hydrophobicity space, external hydrophilic, make water-insoluble organic molecule in organic reaction system, by the hydrophobic binding effect of beta-cyclodextrin cavity, realize the catalyzed reaction (Chem.Rev.1998 in aqueous phase, 98,1743) the environmental protection object effectively reducing solvent usage quantity, is reached.Rely on non-covalent bonding force (hydrogen bond, hydrophobic forces, electrostatic attraction, ionic forces etc.), form beta-cyclodextrin-guest molecule inclusion complex, utilize chirality and the spatial positioning effect of cyclodextrin own cavity, asymmetric organic reactions can be induced to occur, and analogue enztme bound substrates carries out asymmetric catalyzed reaction.
Under basic conditions, there is certain chemical stability based on beta-cyclodextrin, constructing the supramolecule beta-cyclodextrin derivative of specific functional groups by modifying base, catalytic reaction activity and enantioselectivity can be improved.Tabushi etc. introduce Pyridoxylamine on beta-cyclodextrin, the transamination reaction of analogue enztme, in alkalescence buffer solution under normal temperature, and highly selective synthesis L-Trp and L-phenylalanine (J.Am.Chem.Soc., 1985,107,5545.).Utilize compared with amino acid whose reduzate amino alcohol modifies base with general amino alcohol, the constructional feature of chiral molecules has stronger space multistory selectivity, effective to the chiral induction of guest molecule.Therefore, synthesize such beta-cyclodextrin derivative and there is certain theoretical investigation and using value.
Summary of the invention
The object of the present invention is to provide a kind of based on amino acid reduzate amino alcohol beta-cyclodextrin derivative and preparation method thereof and application.
Provided by the invention is that L-benzene glycinol modifies beta-cyclodextrin (CD-1) based on a seed amino acid reduzate amino alcohol beta-cyclodextrin derivative, D-phenylalaninol modifies beta-cyclodextrin (CD-2), L-phenylalaninol modifies beta-cyclodextrin (CD-3), L-Propanolamine modifies beta-cyclodextrin (CD-4), L-valerian ammonia alcohol modifies beta-cyclodextrin (CD-5), L-isoleucine alcohol modifies beta-cyclodextrin (CD-6), L-leucinol modifies beta-cyclodextrin (CD-7), modify the hydroxyl that position is beta-cyclodextrin C-6, its structural formula is as follows:
Wherein,
The invention provides described based on amino acid reduzate amino alcohol beta-cyclodextrin derivative preparation method; said method comprising the steps of: single (6-O-p-tosyl group)-beta-cyclodextrin and amino alcohol are dissolved in anhydrous polar aprotic solvent; under nitrogen atmosphere; stirring reaction at the reaction temperatures, after gained reaction mixture cool to room temperature, is slowly added drop-wise in dehydrated alcohol; leave standstill; suction filtration, recrystallization in water, namely obtains product by the vacuum-drying of gained solid.
Above-mentioned based in amino acid reduzate amino alcohol beta-cyclodextrin derivative preparation method, the mol ratio of described list (6-O-p-tosyl group)-beta-cyclodextrin and amino alcohol is 1:1 ~ 1:100; Described anhydrous polar aprotic solvent is acetonitrile, or hexamethyl-phosphoramide, or DMF, or methyl-sulphoxide; Temperature of reaction is 60 ~ 150 DEG C; Reaction times is 8.0 ~ 120.0h.
Present invention also offers the described application based on amino acid reduzate amino alcohol beta-cyclodextrin derivative, beta-cyclodextrin derivative is applied to aqueous metal catalysis organic synthesis as the water soluble ligand in metalloenzyme catalysis, or aqueous phase molecular recognition aspect.
In above-mentioned application, preferentially this beta-cyclodextrin derivative is applied to the asymmetric reduction of aqueous metal catalysis aromatic ketone, its feature comprises the following steps: beta-cyclodextrin derivative and metal-salt are dissolved in HCOONa2H 2in the O aqueous solution, stirred at ambient temperature, then adds aromatic ketone, after reaction mixture stirring reaction, adds dichloromethane extraction and merges organic layer, anhydrous Na 2sO4 is dry, and obtain transparent liquid after decompression precipitation, described aromatic ketone is the compound with following formula:
Wherein R is selected from methyl, ethyl, propyl group, butyl, sec.-propyl, the tertiary butyl, phenyl, 1-naphthyl, 2-naphthyl, methoxyl group, hydroxyl, amino, methylamino-, chlorine, nitro etc.
Effect of the present invention is embodied in: based on the novel structure of amino acid reduzate amino alcohol beta-cyclodextrin derivative CD-1 ~ CD-7, synthetic method is simple, product environmental protection, yield is high, application is wide, can with metallic ion coordination, in aqueous catalysis organic synthesis, embody excellent enantioselectivity, product ee% is higher.
Embodiment
Below in conjunction with specific embodiment, the present invention is described further, but protection scope of the present invention is not limited in this:
What embodiment 1-8 illustrated is the application of amino acid reduzate amino alcohol beta-cyclodextrin derivative in aqueous metal catalysis organic synthesis.
What embodiment 9 illustrated is the application of amino alcohol beta-cyclodextrin derivative in aqueous phase molecular recognition.
Embodiment 1:
In 250ml eggplant shaped reaction device, single for 32.23g (25.0mmol) (6-O-p-tosyl group)-beta-cyclodextrin and 3.43g (25.0mmol) L-benzene glycinol are dissolved in the anhydrous HMPA of 100mL, in N 2under atmosphere, 110 DEG C of stirring reaction 48.0h.After gained reaction mixture cool to room temperature, be slowly added drop-wise in 200mL dehydrated alcohol, leave standstill, suction filtration, recrystallization twice in water, by gained solid vacuum-drying 4.0h at 110 DEG C, obtains white solid (CD-1) 28.54g, yield 91.07%.
CD-1:m.p.>260℃; 1HNMR(D 2O,400MHz)δ:7.39~7.17(m,7H),5.10~4.86(m,13H),4.07~3.71(m,24H),3.70~3.25(m,28H),3.21~2.93(m,5H),2.79(2H),2.66ppm(m,2H); 13CNMR(DMSO-d 6,400MHz)δ:140.79,128.10~126.96,101.80~101.06,84.12,80.61,72.98~71.86,68.83,66.22,62.84,59.78,46.65ppm;MS(ESI)m/z:1254.4[M+H] +,1276.5[M+Na] +.
Embodiment 2:
In 250ml eggplant shaped reaction device, single for 32.23g (25.0mmol) (6-O-p-tosyl group)-beta-cyclodextrin and 3.78g (25.0mmol) D-phenylalaninol are dissolved in the anhydrous HMPA of 100mL, in N 2under atmosphere, 110 DEG C of stirring reaction 48.0h.After gained reaction mixture cool to room temperature, be slowly added drop-wise in 200mL dehydrated alcohol, leave standstill, suction filtration, recrystallization twice in water, by gained solid vacuum-drying 4.0h at 110 DEG C, obtains white solid (CD-2) 28.73g, yield 90.63%.
CD-2:m.p.>265℃; 1HNMR(D 2O,400MHz)δ:7.37~7.08(m,5H),5.15~4.84(m,10H),3.95~3.72(m,15H),3.70~3.62(m,7H),3.62~3.33(m,18H),3.31~3.15(m,2H),2.92~2.68(m,3H),2.63~2.47(m,2H)ppm;MS(ESI):m/z:1268.5[M+H] +,1290.4[M+Na] +.
Embodiment 3:
In 250ml eggplant shaped reaction device, single for 32.23g (25.0mmol) (6-O-p-tosyl group)-beta-cyclodextrin and 3.78g (25.0mmol) L-phenylalaninol are dissolved in the anhydrous HMPA of 100mL, in N 2under atmosphere, 110 DEG C of stirring reaction 48.0h.After gained reaction mixture cool to room temperature, be slowly added drop-wise in 200mL dehydrated alcohol, leave standstill, suction filtration, recrystallization twice in water, by gained solid vacuum-drying 4.0h at 110 DEG C, obtains white solid (CD-3) 28.96g, yield 91.34%.
CD-3:m.p.>265℃;δ:7.50~7.27(m,4H),7.21~7.06(m,2H),5.17~4.85(m,10H),3.99~3.66(m,24H),3.58~3.32(m,22H),3.31~3.03(m,3H),2.91(1H),2.80~2.46(m,3H)ppm;MS(ESI):m/z:1268.3[M+H] +,1290.3[M+Na] +.
Embodiment 4:
In 250ml eggplant shaped reaction device, single for 32.23g (25.0mmol) (6-O-p-tosyl group)-beta-cyclodextrin and 1.87g (25.0mmol) L-Propanolamine are dissolved in the anhydrous HMPA of 100mL, in N 2under atmosphere, 110 DEG C of stirring reaction 48.0h.After gained reaction mixture cool to room temperature, be slowly added drop-wise in 200mL dehydrated alcohol, leave standstill, suction filtration, recrystallization twice in water, by gained solid vacuum-drying 4.0h at 110 DEG C, obtains white solid (CD-4) 27.78g, yield 93.22%.
CD-4:m.p.>250℃; 1HNMR(D 2O,400MHz)δ:5.16~4.92(m,11H),4.27~3.70(m,35H),3.67~3.29(m,23H),3.10~2.29(m,2H),2.85~2.68(m,3H),2.21(m,1H),1.00ppm(m,3H);MS(ESI):m/z:1192.5[M+H] +,1214.5[M+Na] +.
Embodiment 5:
In 250ml eggplant shaped reaction device, single for 32.23g (25.0mmol) (6-O-p-tosyl group)-beta-cyclodextrin and 2.58g (25.0mmol) L-valerian ammonia alcohol are dissolved in the anhydrous HMPA of 100mL, in N 2under atmosphere, 110 DEG C of stirring reaction 48.0h.After gained reaction mixture cool to room temperature, be slowly added drop-wise in 200mL dehydrated alcohol, leave standstill, suction filtration, recrystallization twice in water, by gained solid vacuum-drying 4.0h at 110 DEG C, obtains white solid (CD-5) 27.63g, yield 90.59%.
CD-5:m.p.>255℃; 1HNMR(D 2O,400MHz)δ:5.13~4.91(m,10H),4.34~3.93(m,14H),3.91~3.64(m,19H),3.61~3.26(m,13H),3.17~2.15(m,1H),1.83(m,1H),1.01~0.62ppm(m,3H);MS(ESI):m/z:1220.5[M+H] +,1242.5[M+Na] +.
Embodiment 6:
In 250ml eggplant shaped reaction device, single for 32.23g (25.0mmol) (6-O-p-tosyl group)-beta-cyclodextrin and 2.93g (25.0mmol) L-isoleucine alcohol are dissolved in the anhydrous HMPA of 100mL, in N 2under atmosphere, 110 DEG C of stirring reaction 48.0h.After gained reaction mixture cool to room temperature, be slowly added drop-wise in 200mL dehydrated alcohol, leave standstill, suction filtration, recrystallization twice in water, by gained solid vacuum-drying 4.0h at 110 DEG C, obtains white solid (CD-6) 27.34g, yield 88.60%.
CD-6::m.p.>260℃; 1HNMR(D 2O,400MHz)δ:5.20~4.90(m,14H),4.12~3.74(m,26H),3.71~3.44(m,26H),3.41~3.24(m,4H),3.05~2.95(m,1H),2.88~2.44(m,3H),1.56(1H),1.31~1.03(m,2H),0.97~0.79(m,4H),0.78~0.64(m,3H)ppm;MS(ESI):m/z:1234.5[M+H] +,1256.6[M+Na] +.
Embodiment 7:
In 250ml eggplant shaped reaction device, single for 32.23g (25.0mmol) (6-O-p-tosyl group)-beta-cyclodextrin and 2.93g (25.0mmol) L-leucinol are dissolved in the anhydrous HMPA of 100mL, in N 2under atmosphere, 110 DEG C of stirring reaction 48.0h.After gained reaction mixture cool to room temperature, be slowly added drop-wise in 200mL dehydrated alcohol, leave standstill, suction filtration, recrystallization twice in water, by gained solid vacuum-drying 4.0h at 110 DEG C, obtains white solid (CD-7) 27.93g, yield 90.52%.
CD-7:m.p.>260℃; 1HNMR(D 2O,400MHz)δ:5.17~5.08(m,1H),5.05~4.89(m,6H),4.05~3.89(m,2H),3.88~3.73(m,17H),3.70~3.41(m,22H),3.36~3.20(m,3H),3.14~2.99(m,2H),2.84~2.59(m,3H),1.49(1H),1.19~0.95(m,2H),0.91~0.78(m,6H)ppm;MS(ESI):m/z:1234.6[M+H] +,1256.6[M+Na] +.
Embodiment 8:
In 500ml round-bottomed flask, by 5mmol beta-cyclodextrin derivative (CD-1 ~ CD-7) and metal-salt 0.425g (2.5mmol) CuCl 22H 2o is dissolved in the HCOONa2H of 200ml 2in O (50.0mmol) aqueous solution, after stirred at ambient temperature 1.0h, add 1-acetonaphthone 42.55g (250mmol), after continuing stirring reaction 1.0h, reactant is placed in 0 DEG C of stirring reaction 12h, mixed solution 4 × 50ml dichloromethane extraction merges organic layer, anhydrous Na 2sO 4drying, decompression precipitation, obtain transparent liquid, HPLC analyzes (V normal hexane: V virahol=95:5,0.5mL/min, 254nm), yield 93%, ee%, 91% (R).
Embodiment 9:
In aqueous, the concentration (6.0 × 10 of fixing methyl phenyl ketone -5mol/L), the concentration adding beta-cyclodextrin derivative (CD-4, CD-5, CD-6, CD-7) respectively gets 6.0 × 10 -4mol/L, after 25 DEG C of stirring vibration 24h, take beta-cyclodextrin derivative as reference, measure its ultra-violet absorption spectrum and change successively, at maximum absorption 246nm place, it is 0.6688 that methyl phenyl ketone ultra-violet absorption spectrum raises successively from 0.6645,0.6673,0.6658,0.6651, illustrate that methyl phenyl ketone uv-absorbing changes with different beta-cyclodextrin derivative, this is because different beta-cyclodextrin derivative forms the change of methyl phenyl ketone ultra-violet absorption spectrum to the molecular recognition of methyl phenyl ketone in aqueous phase.

Claims (9)

1. one kind based on amino acid reduzate amino alcohol beta-cyclodextrin derivative, its feature comprises: L-benzene glycinol modifies beta-cyclodextrin, D-phenylalaninol modifies beta-cyclodextrin, L-phenylalaninol modifies beta-cyclodextrin, L-Propanolamine modifies beta-cyclodextrin, L-valerian ammonia alcohol modifies beta-cyclodextrin, and L-isoleucine alcohol modifies beta-cyclodextrin, and L-leucinol modifies beta-cyclodextrin; Modify the hydroxyl that position is beta-cyclodextrin C-6, its structural formula is as follows:
Wherein,
2. described in claim 1 based on the preparation method of amino acid reduzate amino alcohol beta-cyclodextrin derivative; its feature comprises step: be dissolved in anhydrous polar aprotic solvent by single (6-O-p-tosyl group)-beta-cyclodextrin and amino alcohol; under nitrogen atmosphere; stirring reaction at the reaction temperatures, after gained reaction mixture cool to room temperature, is slowly added drop-wise in dehydrated alcohol; leave standstill; suction filtration, recrystallization in water, namely obtains product by the vacuum-drying of gained solid.
3. preparation method according to claim 2, is characterised in that the mol ratio of described list (6-O-p-tosyl group)-beta-cyclodextrin and amino alcohol is 1:1 ~ 1:100.
4. preparation method according to claim 2, described anhydrous polar aprotic solvent is the one in acetonitrile, hexamethyl-phosphoramide, DMF and methyl-sulphoxide.
5. preparation method according to claim 2, is characterized in that temperature of reaction is 60 ~ 150 DEG C; Reaction times is 8.0 ~ 120.0h.
6. be according to claim 1ly aqueous metal catalysis organic synthesis based on amino acid reduzate amino alcohol beta-cyclodextrin derivative, or the application in aqueous phase molecular recognition.
7. application according to claim 6, is characterized in that, the application of described beta-cyclodextrin derivative in aqueous metal catalysis aromatic ketone asymmetric reduction.
8. application according to claim 7, is characterized in that comprising the following steps: beta-cyclodextrin derivative and metal-salt are dissolved in HCOONa2H 2in the O aqueous solution, stirred at ambient temperature, then adds aromatic ketone, after reaction mixture stirring reaction, adds dichloromethane extraction and merges organic layer, anhydrous Na 2sO4 is dry, obtains transparent liquid after decompression precipitation.
9. according to the application of claim 7 or 8, it is characterized in that, described aromatic ketone is the compound with following formula:
Wherein R is selected from methyl, ethyl, propyl group, butyl, sec.-propyl, the tertiary butyl, phenyl, 1-naphthyl, 2-naphthyl, methoxyl group, hydroxyl, amino, methylamino-, chlorine or nitro.
CN201510661366.8A 2015-10-14 2015-10-14 Beta-cyclodextrin derivatives based on amino acid reduced product alkamine and preparation method and application of beta-cyclodextrin derivative Pending CN105175580A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510661366.8A CN105175580A (en) 2015-10-14 2015-10-14 Beta-cyclodextrin derivatives based on amino acid reduced product alkamine and preparation method and application of beta-cyclodextrin derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510661366.8A CN105175580A (en) 2015-10-14 2015-10-14 Beta-cyclodextrin derivatives based on amino acid reduced product alkamine and preparation method and application of beta-cyclodextrin derivative

Publications (1)

Publication Number Publication Date
CN105175580A true CN105175580A (en) 2015-12-23

Family

ID=54898078

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510661366.8A Pending CN105175580A (en) 2015-10-14 2015-10-14 Beta-cyclodextrin derivatives based on amino acid reduced product alkamine and preparation method and application of beta-cyclodextrin derivative

Country Status (1)

Country Link
CN (1) CN105175580A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109824801A (en) * 2019-02-20 2019-05-31 江南大学 A kind of synthetic method of cyclodextrin modified DOPA amine derivative
CN110590973A (en) * 2019-10-28 2019-12-20 滕州京腾鑫汇新材料科技有限公司 Cyclodextrin derivatives and process for producing the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760017A (en) * 1993-12-22 1998-06-02 Commissariat A L'energie Atomique Cyclodextrin derivatives usable in particular for solubilizing hydrophobic chemical compounds such as medicaments and their preparation process
CN101235104A (en) * 2007-01-31 2008-08-06 北京理工大学 Six kinds of alpha-schiff base derived beta-cyclodextrin and use
CN102585040A (en) * 2012-02-03 2012-07-18 中山大学 Beta-cyclodextrin derivative based on annular alkamine as well as preparation method and application of beta-cyclodextrin derivative
CN102627704A (en) * 2012-03-26 2012-08-08 中山大学 Beta-cyclodextrin derivative and preparation method and application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760017A (en) * 1993-12-22 1998-06-02 Commissariat A L'energie Atomique Cyclodextrin derivatives usable in particular for solubilizing hydrophobic chemical compounds such as medicaments and their preparation process
CN101235104A (en) * 2007-01-31 2008-08-06 北京理工大学 Six kinds of alpha-schiff base derived beta-cyclodextrin and use
CN102585040A (en) * 2012-02-03 2012-07-18 中山大学 Beta-cyclodextrin derivative based on annular alkamine as well as preparation method and application of beta-cyclodextrin derivative
CN102627704A (en) * 2012-03-26 2012-08-08 中山大学 Beta-cyclodextrin derivative and preparation method and application thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109824801A (en) * 2019-02-20 2019-05-31 江南大学 A kind of synthetic method of cyclodextrin modified DOPA amine derivative
CN109824801B (en) * 2019-02-20 2021-05-18 江南大学 Synthesis method of cyclodextrin modified dopamine derivative
CN110590973A (en) * 2019-10-28 2019-12-20 滕州京腾鑫汇新材料科技有限公司 Cyclodextrin derivatives and process for producing the same
CN110590973B (en) * 2019-10-28 2021-11-05 淮北云端文化传媒有限公司 Cyclodextrin derivatives and process for producing the same

Similar Documents

Publication Publication Date Title
WO2008047057A1 (en) Method for preparing cyclodextrin oligomers or polymers, products obtained and uses
EP3380526B1 (en) Environmentally friendly process for the preparation of nanocellulose and derivatives thereof
CN105175580A (en) Beta-cyclodextrin derivatives based on amino acid reduced product alkamine and preparation method and application of beta-cyclodextrin derivative
CN110818600A (en) Method for preparing β -carbonyl sulfone
CN104098501A (en) 3-difluoro alkyl substituted all-carbon quaternary carbon oxoindole derivative and synthetic method thereof
AU2013269340B2 (en) Method of synthesising sulforaphane
Zhao et al. Surface-up constructed tandem-inverted bilayer cyclodextrins for enhanced enantioseparation and adsorption
Mouradzadegun et al. Tetraphenolate c-methylcalix [4] resorcinarene as a new heterogeneous phase transfer catalyst for ring-opening of triaryl substituted pyrylium salts in aqueous biphasic medium
CN102627704A (en) Beta-cyclodextrin derivative and preparation method and application thereof
Santacruz et al. Gold nanoparticles decorated with a cinchonine organocatalyst: application in the asymmetric α-amination of β-ketoesters
JP2007238540A (en) Method for producing optically active alcohol compound
CN104119459A (en) Preparation method of cyclodextrin hybrid alkyl skeleton chiral stationary phase
CN105272987A (en) Preparation method of 3-cyano-N-confused porphyrin compound
JP5230956B2 (en) Method for solubilizing hydrophobic macromolecules using quaternary ammonium salts
CN102585040B (en) Beta-cyclodextrin derivative based on annular alkamine as well as preparation method and application of beta-cyclodextrin derivative
JP2022069882A (en) Novel compound and anion receptor
CN111087402B (en) Method for asymmetrically synthesizing Epicocin G alkaloid of ETP natural product
JP2009024094A (en) New cyclodextrin compound
Yazerski et al. Molecularly enlarged S, S-BnTsDPEN ligands for iron-catalyzed asymmetric olefin epoxidation reactions using hydrogen peroxide
KR101002795B1 (en) Novel Retinyl Ascorbate Compounds and Preparation Method thereof
CN112028802B (en) Method for preparing N, N-dimethyl phenyl dithioacetate compound by grinding method
CN115304465B (en) Green method for converting 1, 3-dithiane derivative into carbonyl compound
Mazzaglia et al. Synthesis and characterization of poly (amidoamine)-platinum (II) complexes. Detailed speciation by Matrix-Assisted Laser Desorption Ionization Mass Spectrometry
RU2448954C1 (en) Method of producing sulphoxides
EP1086142B1 (en) Region-selective method for preparing cyclodextrin c-6 monosulphonyl derivatives

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20151223

WD01 Invention patent application deemed withdrawn after publication